Last reviewed · How we verify
Preoperative chemotherapy — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Preoperative chemotherapy (Preoperative chemotherapy) — CNAO National Center of Oncological Hadrontherapy. Preoperative chemotherapy involves administering chemotherapy before surgery to reduce tumor size and improve surgical outcomes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Preoperative chemotherapy TARGET | Preoperative chemotherapy | CNAO National Center of Oncological Hadrontherapy | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Preoperative chemotherapy CI watch — RSS
- Preoperative chemotherapy CI watch — Atom
- Preoperative chemotherapy CI watch — JSON
- Preoperative chemotherapy alone — RSS
Cite this brief
Drug Landscape (2026). Preoperative chemotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/preoperative-chemotherapy. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing